Odonate Therapeutics Statistics Share Statistics Odonate Therapeutics has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 782.3K, so 0% of the outstanding
shares have been sold short.
Short Interest 782.3K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -4.99 and the forward
PE ratio is null.
Odonate Therapeutics's PEG ratio is
1.01.
PE Ratio -4.99 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 4.63 P/FCF Ratio -5.55 PEG Ratio 1.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Odonate Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.91,
with a Debt / Equity ratio of 0.04.
Current Ratio 5.91 Quick Ratio 5.91 Debt / Equity 0.04 Debt / EBITDA -0.04 Debt / FCF -0.05 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-922.26K Employee Count 137 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1.08M Effective Tax Rate -0.86%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.45, so Odonate Therapeutics's
price volatility has been higher than the market average.
Beta 0.45 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 959,817
Income Statement
Revenue n/a Gross Profit n/a Operating Income -127.43M Net Income -126.35M EBITDA -125.91M EBIT -127.43M Earnings Per Share (EPS) -3.85
Full Income Statement Balance Sheet The company has 157.26M in cash and 5.33M in
debt, giving a net cash position of 151.94M.
Cash & Cash Equivalents 157.26M Total Debt 5.33M Net Cash 151.94M Retained Earnings -366.43M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -113.13M
and capital expenditures -432K, giving a free cash flow of -113.56M.
Operating Cash Flow -113.13M Capital Expenditures -432K Free Cash Flow -113.56M FCF Per Share -3.46
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
